Trial Profile
Multicenter, retrospective, 12 month study of Elvitegravir/emtricitabine/tenofovir-disoproxil-fumarate/cobicistat (Stribild) in a Spanish Region in HIV-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 01 Mar 2016 New trial record